Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study.
Procopio G, Apollonio G, Cognetti F, Miceli R, Milella M, Mosca A, Chiuri VE, Bearz A, Morelli F, Ortega C, Atzori F, Donini M, Ratta R, Raimondi A, Claps M, Martinetti A, Capitanio U, de Braud FG, Cappelletti V, Verzoni E.
Procopio G, et al. Among authors: claps m.
Eur Urol Oncol. 2019 Nov;2(6):699-707. doi: 10.1016/j.euo.2019.08.011. Epub 2019 Sep 19.
Eur Urol Oncol. 2019.
PMID: 31542243
Clinical Trial.